Fig. 2
From: Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway
(A) Contribution of three databases to atherosclerotic disease-relevant targets. (B) On the left is a Venn diagram of NOB binding targets and atherosclerotic disease-associated targets. The PPI network constructed from STRING is shown on the right. (C) Based on the GO enrichment analysis, functions in which NOB targets may be involved in atherosclerosis, including biological processes, cellular components and molecular functions, were identified. (D) KEGG analysis results showing pivotal signaling pathways associated with NOB intervention in atherosclerosis. The dimension of the bubbles shows the number of genes, and the color stands for the P-value. (E) A network of NOB intervention in atherosclerosis. (F) The top 10 core targets through which NOB may intervene in atherosclerosis according to the degree method are depicted in the bar plot